These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8516657

  • 1. Risk factors, co-medication, and concomitant diseases: their influence on the outcome of therapy with cisapride.
    Fehr HF.
    Scand J Gastroenterol Suppl; 1993; 195():40-5; discussion 45-6. PubMed ID: 8516657
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Factors affecting short- and long-term outcome of a short therapeutic trial with cisapride in dyspeptic patients.
    Heyse PM, Rambaldo R, Hazelhoff B.
    Scand J Gastroenterol Suppl; 1993; 195():15-23; discussion 23-4. PubMed ID: 8516654
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of cisapride therapy for severe dyspepsia on gastrointestinal symptoms and quality of life.
    Abell TL, Cutts TF, Cooper T.
    Scand J Gastroenterol Suppl; 1993; 195():60-3; discussion 63-4. PubMed ID: 8516661
    [Abstract] [Full Text] [Related]

  • 12. Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia.
    Archimandritis A, Tzivras M, Fertakis A, Emmanuel A, Laoudi F, Kalantzis N, Anthopoulou H, Michailidis D.
    Clin Ther; 1992; 14(4):553-61. PubMed ID: 1525789
    [Abstract] [Full Text] [Related]

  • 13. Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia.
    Rezende-Filho J, Di Lorenzo C, Dooley CP, Valenzuela JE.
    Dig Dis Sci; 1989 Jul; 34(7):1057-62. PubMed ID: 2743845
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chronic functional dyspepsia: short- and medium-term outcome of a therapeutic trial with cisapride.
    Rösch W.
    Clin Ther; 1994 Jul; 16(3):437-45. PubMed ID: 7923310
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Longterm oral cisapride improves interdigestive antroduodenal motility in dyspeptic patients.
    Testoni PA, Bagnolo F, Fanti L, Passaretti S, Tittobello A.
    Gut; 1990 Mar; 31(3):286-90. PubMed ID: 2323591
    [Abstract] [Full Text] [Related]

  • 18. Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study.
    Deruyttere M, Lepoutre L, Heylen H, Samain H, Pennoit H.
    Clin Ther; 1987 Mar; 10(1):44-51. PubMed ID: 3329964
    [Abstract] [Full Text] [Related]

  • 19. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
    Champion MC, MacCannell KL, Thomson AB, Tanton R, Eberhard S, Sullivan SN, Archambault A.
    Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.